| P50 | author | Odile Launay | Q65089382 |
| P2093 | author name string | Xavier Duval | |
| | Ulrich Zimmermann | |
| | Christine Sadorge | |
| | Florence Galtier | |
| | Patrick Richard | |
| | Henri Laurichesse | |
| | Benoit Soubeyrand | |
| P2860 | cites work | Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q71520995 |
| | Updated vaccine guidelines for aging and aged citizens of Europe | Q83080705 |
| | Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008 | Q85198846 |
| | Two-sided confidence intervals for the single proportion: comparison of seven methods | Q28271313 |
| | Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects | Q33482852 |
| | Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. | Q34158752 |
| | Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, suppo | Q34590779 |
| | Pertussis serodiagnosis in Belgium from 1990 to 2009. | Q35066316 |
| | Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents | Q36226040 |
| | What is new in pertussis? | Q36296318 |
| | Pertussis immunisation in adolescents and adults | Q37056489 |
| | Vaccination in older adults: development of an educational tool, Vaxisenior, in France | Q37700571 |
| | Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults | Q37806198 |
| | Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial | Q38453314 |
| | Resurgence of pertussis in Europe | Q40390869 |
| | Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk | Q41219727 |
| | Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history | Q46193241 |
| | Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults | Q46981537 |
| P433 | issue | 12 | |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| P304 | page(s) | 1875-1881 | |
| P577 | publication date | 2012-10-02 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries | |
| P478 | volume | 8 | |